4FSF

Crystal structure of Pseudomonas aeruginosa PBP3 complexed with compound 14


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.20 Å
  • R-Value Free: 
    0.275 (Depositor), 0.289 (DCC) 
  • R-Value Work: 
    0.216 (Depositor), 0.223 (DCC) 
  • R-Value Observed: 
    0.220 (Depositor) 

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 

Created with Raphaël 2.3.0Worse 01 BetterLigand structure goodness of fit to experimental dataBest fitted 0W0Click on this verticalbar to view details

This is version 1.1 of the entry. See complete history


Literature

Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infections.

Mitton-Fry, M.J.Arcari, J.T.Brown, M.F.Casavant, J.M.Finegan, S.M.Flanagan, M.E.Gao, H.George, D.M.Gerstenberger, B.S.Han, S.Hardink, J.R.Harris, T.M.Hoang, T.Huband, M.D.Irvine, R.Lall, M.S.Megan Lemmon, M.Li, C.Lin, J.McCurdy, S.P.Mueller, J.P.Mullins, L.Niosi, M.Noe, M.C.Pattavina, D.Penzien, J.Plummer, M.S.Risley, H.Schuff, B.P.Shanmugasundaram, V.Starr, J.T.Sun, J.Winton, J.Young, J.A.

(2012) Bioorg Med Chem Lett 22: 5989-5994

  • DOI: https://doi.org/10.1016/j.bmcl.2012.07.005
  • Primary Citation of Related Structures:  
    4FSF

  • PubMed Abstract: 

    Novel siderophore-linked monobactams with in vitro and in vivo anti-microbial activity against MDR Gram-negative pathogens are described.


  • Organizational Affiliation

    Medicinal Chemistry, Pfizer Worldwide Research and Development, Eastern Point Road, Groton, CT 06340, USA.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Penicillin-binding protein 3536Pseudomonas aeruginosaMutation(s): 0 
Gene Names: ftsI
EC: 3.4.16.4
UniProt
Find proteins for Q51504 (Pseudomonas aeruginosa)
Explore Q51504 
Go to UniProtKB:  Q51504
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ51504
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
0W0
Query on 0W0

Download Ideal Coordinates CCD File 
B [auth A](4R,5S,8Z)-8-(2-amino-1,3-thiazol-4-yl)-1-[3-(1,5-dihydroxy-4-oxo-1,4-dihydropyridin-2-yl)-1,2-oxazol-5-yl]-5-formyl-11,11-dimethyl-1,7-dioxo-4-(sulfoamino)-10-oxa-2,6,9-triazadodec-8-en-12-oic acid
C22 H24 N8 O13 S2
OFOVQVNKWTUULV-NEEHKMPWSA-N
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.20 Å
  • R-Value Free:  0.275 (Depositor), 0.289 (DCC) 
  • R-Value Work:  0.216 (Depositor), 0.223 (DCC) 
  • R-Value Observed: 0.220 (Depositor) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 67.64α = 90
b = 82.723β = 90
c = 88.747γ = 90
Software Package:
Software NamePurpose
HKL-2000data collection
PHASERphasing
BUSTERrefinement
HKL-3000data reduction
SCALEPACKdata scaling

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 

Created with Raphaël 2.3.0Worse 01 BetterLigand structure goodness of fit to experimental dataBest fitted 0W0Click on this verticalbar to view details

Entry History 

Deposition Data

  • Released Date: 2012-10-17 
  • Deposition Author(s): Han, S.

Revision History  (Full details and data files)

  • Version 1.0: 2012-10-17
    Type: Initial release
  • Version 1.1: 2024-11-20
    Changes: Data collection, Database references, Derived calculations, Structure summary